about
Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysisRegional decoupling of N-acetyl-aspartate and glutamate in schizophreniaMultimodal analysis of the hippocampus in schizophrenia using proton magnetic resonance spectroscopy and functional magnetic resonance imaging.Abnormalities in large scale functional networks in unmedicated patients with schizophrenia and effects of risperidone.Aberrant Hippocampal Connectivity in Unmedicated Patients With Schizophrenia and Effects of Antipsychotic Medication: A Longitudinal Resting State Functional MRI Study.Proton magnetic resonance spectroscopy of the substantia nigra in schizophreniaVentral tegmental area/midbrain functional connectivity and response to antipsychotic medication in schizophrenia.Risperidone Effects on Brain Dynamic Connectivity-A Prospective Resting-State fMRI Study in Schizophrenia.Ketamine modulates hippocampal neurochemistry and functional connectivity: a combined magnetic resonance spectroscopy and resting-state fMRI study in healthy volunteersHippocampal-parietal dysconnectivity and glutamate abnormalities in unmedicated patients with schizophrenia.Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia.A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia.The Problem of Spurious Correlations Between Pairs of Brain Metabolite Values Measured in the Same Voxel With Magnetic Resonance Spectroscopy—ReplyMnemonic Discrimination Deficits in First-Episode Psychosis and a Ketamine Model Suggests Dentate Gyrus Pathology Linked to N-Methyl-D-Aspartate Receptor HypofunctionRapid Clozapine Titration in an Acutely Agitated Patient With Schizoaffective DisorderNeurometabolic correlates of 6 and 16 weeks of treatment with risperidone in medication-naive first-episode psychosis patientsHippocampal glutamate and hippocampus subfield volumes in antipsychotic-naive first episode psychosis subjects and relationships to duration of untreated psychosisWhite matter integrity, duration of untreated psychosis, and antipsychotic treatment response in medication-naïve first-episode psychosis patients
P50
Q30565982-FEED27B6-D54D-429D-B5CF-2B6895C7BD72Q36323522-B3549591-3FC0-452F-AC9B-04BA4CFAE3E4Q36351638-E24E3ED6-B795-45AD-8011-62ACA52D26FAQ36382573-8894B684-F2E3-41AC-91EA-DF42A33B778DQ36994859-0C228111-C325-4DA2-899A-D7B191669755Q37141400-99EFDA8D-C120-4495-B230-FA56A264C5D1Q37584279-AC42C3B0-7B47-4E48-A0D4-78615C0C5E61Q37625470-2CD42B8B-4387-4798-9CC4-04C79DAEA96EQ39536837-5B4E10BC-09C9-44D1-91C0-8D993A032651Q48647823-B3A627D6-5606-4D4F-9B59-DB525B6C4DF2Q48948657-84EE1322-6436-46E6-AD5F-C0AAA35F4CD0Q49070894-1C17B0F3-4DB2-4BF0-B59E-E35BA1A65DA4Q58406862-3EB8C594-DD28-4B4C-8EF8-70B1603C9030Q59880655-0E801134-0B03-469D-BC61-9AD487B35FA9Q59880742-7BF41492-1249-4563-B7D0-B080DACCFA03Q89747397-227DBABB-256F-4302-945B-4FB70920A8B2Q94599682-30C674CB-6228-4CFC-9B4F-089887B55F85Q94599929-BA82135C-4C18-4C21-B21D-D4E7A3C4AFC0
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nina V Kraguljac
@es
Nina V Kraguljac
@nl
Nina V Kraguljac
@sl
Nina V. Kraguljac
@en
type
label
Nina V Kraguljac
@es
Nina V Kraguljac
@nl
Nina V Kraguljac
@sl
Nina V. Kraguljac
@en
prefLabel
Nina V Kraguljac
@es
Nina V Kraguljac
@nl
Nina V Kraguljac
@sl
Nina V. Kraguljac
@en
P1053
N-4416-2017
P106
P1153
55313007700
P21
P31
P3829
P496
0000-0003-2567-4098
P569
2000-01-01T00:00:00Z